GenixPharmaceucticals Corporation (GENX) — Financial Flexibility Index
GenixPharmaceucticals Corporation (GENX) has a Financial Flexibility Index of -0.02x as of January 2026. Free cash flow of CA$-30.25K (operating CF CA$-30.25K minus capex CA$0.00) represents 0% of total liabilities (CA$1.51 Million). Also explore GenixPharmaceucticals Corporation annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GenixPharmaceucticals Corporation Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for GenixPharmaceucticals Corporation across 11 annual periods. Check GENX strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for GenixPharmaceucticals Corporation (2015–2025)
Year-by-year free cash flow to debt coverage for GenixPharmaceucticals Corporation. For the full company profile including market capitalisation, see how much is GenixPharmaceucticals Corporation worth.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.08x | CA$-124.07K | CA$-124.07K | CA$1.47 Million | ▲ +44.7% |
| 2024 | -0.15x | CA$-187.34K | CA$-187.34K | CA$1.23 Million | ▲ +6.0% |
| 2023 | -0.16x | CA$-220.67K | CA$-220.67K | CA$1.36 Million | ▲ +21.0% |
| 2022 | -0.21x | CA$-216.24K | CA$-219.58K | CA$1.05 Million | ▲ +63.8% |
| 2021 | -0.57x | CA$-428.31K | CA$-428.31K | CA$755.19K | ▼ -42.5% |
| 2020 | -0.40x | CA$-195.03K | CA$-195.03K | CA$489.88K | ▲ +44.0% |
| 2019 | -0.71x | CA$-58.55K | CA$-58.55K | CA$82.41K | ▼ -326.9% |
| 2018 | 0.31x | CA$34.18K | CA$34.18K | CA$109.15K | ▲ +1013.5% |
| 2017 | -0.03x | CA$-9.35K | CA$-9.35K | CA$272.80K | ▲ +98.6% |
| 2016 | -2.43x | CA$-165.07K | CA$-165.07K | CA$68.04K | ▲ +35.8% |
| 2015 | -3.78x | CA$-418.84K | CA$-452.55K | CA$110.78K | — |